A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.

advanced gastric cancer chemotherapy 5-fluorouracil oxaliplatin pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY Despite a decreasing trend in its incidence, gastric cancer remains the second most common cause of cancer-related death ( Parkin, 1998 ); furthermore, there was a change in the site of origin within the stomach, with a rising incidence of cancer of cardia and gastroesophageal junction ( Blot et al , 1991 ).

also in 47,180 other papers